[go: up one dir, main page]

MX2009003741A - Liquid chalcogenide compositions and methods of manufacturing and using the same. - Google Patents

Liquid chalcogenide compositions and methods of manufacturing and using the same.

Info

Publication number
MX2009003741A
MX2009003741A MX2009003741A MX2009003741A MX2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A
Authority
MX
Mexico
Prior art keywords
manufacturing
methods
same
chalcogenide compositions
compositions
Prior art date
Application number
MX2009003741A
Other languages
Spanish (es)
Inventor
Edward Wintner
Thomas L Deckwerth
Kevin J Tomaselli
Paul A Hill
Csaba Szabo
Original Assignee
Ikaria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikaria Inc filed Critical Ikaria Inc
Publication of MX2009003741A publication Critical patent/MX2009003741A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Oil, Petroleum & Natural Gas (AREA)

Abstract

The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and prevention of ischemic or hypoxic injury, as well as in the preservation of biological matter.
MX2009003741A 2006-10-05 2007-10-05 Liquid chalcogenide compositions and methods of manufacturing and using the same. MX2009003741A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84990006P 2006-10-05 2006-10-05
US89672707P 2007-03-23 2007-03-23
PCT/US2007/080613 WO2008043081A2 (en) 2006-10-05 2007-10-05 Liquid chalcogenide compositions and methods of manufacturing and using the same

Publications (1)

Publication Number Publication Date
MX2009003741A true MX2009003741A (en) 2009-07-10

Family

ID=39149128

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003741A MX2009003741A (en) 2006-10-05 2007-10-05 Liquid chalcogenide compositions and methods of manufacturing and using the same.

Country Status (12)

Country Link
US (1) US20080187604A1 (en)
EP (1) EP2068893A2 (en)
JP (1) JP5303465B2 (en)
KR (2) KR20150042291A (en)
CN (1) CN101534844B (en)
AU (1) AU2007303050B2 (en)
BR (1) BRPI0719539A2 (en)
CA (1) CA2664341C (en)
IL (1) IL197945A (en)
MX (1) MX2009003741A (en)
NZ (1) NZ575671A (en)
WO (1) WO2008043081A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2605631A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
US20100143503A1 (en) * 2006-12-22 2010-06-10 Ikaria, Inc. Combinations of nitric oxide and sulfide and methods of use and manufacture thereof
JP2010530001A (en) * 2007-06-15 2010-09-02 イカリア， インコーポレイテッド Compositions containing sulfides alone or in combination with nitric oxide and uses thereof
US20080318864A1 (en) * 2007-06-25 2008-12-25 Fred Hutchinson Cancer Research Center Methods and compositions regarding polychalcogenide compositions
US20100183748A1 (en) * 2009-01-21 2010-07-22 Ikaria, Inc. Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury
US20100198338A1 (en) * 2009-01-30 2010-08-05 Medtronic Vascular, Inc., A Delaware Corporation Hydrogen Sulfide Donating Polymers
US8541396B2 (en) 2009-04-24 2013-09-24 National University Of Singapore Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
WO2011079222A2 (en) 2009-12-23 2011-06-30 Boston Scientific Scimed, Inc. Less traumatic method of delivery of mesh-based devices into human body
US8182830B2 (en) * 2010-01-05 2012-05-22 Medtronic Vascular, Inc. Hydrogen sulfide generating polymers
WO2013081684A2 (en) * 2011-08-19 2013-06-06 Northeastern University Chemical sensor based on highly organized single walled carbon nanotube networks
AU2013274325A1 (en) * 2012-06-13 2014-12-11 Fred Hutchinson Cancer Research Center Compositions comprising chalcogenides and related methods
TW201420130A (en) * 2012-09-26 2014-06-01 Neochemir Inc Liquid agent containing dissolved carbon dioxide and administrating method thereof
BR112015015092A2 (en) * 2012-12-31 2017-07-11 Somahlution Llc processes for preserving tissue or organ function and for preparing preservative formulation and kit
JP2014201580A (en) * 2013-04-10 2014-10-27 株式会社昭和冷凍プラント Treatment liquid for storage or cleaning of transplanted organ using nitrogen water and preparation method thereof
MX386702B (en) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center HALOGEN TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY.
CN107809996A (en) * 2015-04-29 2018-03-16 Bsn医疗有限公司 Multistage method caused by nitric oxide
CN106539818A (en) * 2015-09-20 2017-03-29 复旦大学 Hydrogen sulfide and its donor sodium hydrosulfide are preparing the purposes promoted in hemopoietic medicine
CN105964217B (en) * 2016-06-17 2018-10-12 中国科学院城市环境研究所 A kind of magnetism KMS-1/Fe3O4The preparation method of composite material and its for removing Ciprofloxacin
EP3299021A1 (en) * 2016-09-21 2018-03-28 Universitätsklinikum Jena Thiosulfate for treating hepatic ischemia/reperfusion injury
JP6989157B2 (en) * 2017-02-09 2022-01-05 ノクサノ インコーポレイテッド Electrochemical gaseous transmitter production composition and its usage, as well as dressings and therapeutic systems incorporating it
WO2019036722A1 (en) 2017-08-18 2019-02-21 Northeastern University Method of tetratenite production and system therefor
CN111278476B (en) 2017-09-22 2023-01-17 贝克顿·迪金森公司 4% trisodium citrate solution as catheter lock solution
US20220105126A1 (en) * 2020-10-02 2022-04-07 Craig Mercer Boulris Composition for preventing and treating microbial disease
US11679119B2 (en) 2021-09-24 2023-06-20 MAIA Pharmaceuticals, Inc. Bortezomib compositions
CN115040648B (en) * 2022-06-02 2023-07-28 中山大学 A nanoparticle based on hydrogen sulfide to promote calcium overload and photothermal specific treatment of tumors and its preparation method
CN116804630B (en) * 2023-08-03 2024-03-05 中拓生物有限公司 Serum homocysteine assay kit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364555A (en) 1991-04-30 1994-11-15 Advanced Oxygen Technologies, Inc. Polymer compositions containing salicylic acid chelates as oxygen scavengers
US6458758B1 (en) 1993-08-16 2002-10-01 Synzyme Technologies, Inc. Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
CA2650204A1 (en) 1996-12-31 1998-07-09 Harry B. Demopoulos Pharmaceutical preparations of glutathione and methods of administration thereof
AU2004283729A1 (en) 2003-10-22 2005-05-06 Fred Hutchinson Cancer Research Center Methods, compositions and devices for inducing stasis in cells
US20050106214A1 (en) 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
CA2605631A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
WO2006119258A2 (en) * 2005-04-29 2006-11-09 University Of Houston Use of hydrogen sulfide in the treatment of eye diseases
CA2646674A1 (en) * 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions

Also Published As

Publication number Publication date
WO2008043081A2 (en) 2008-04-10
IL197945A0 (en) 2009-12-24
NZ575671A (en) 2011-04-29
CA2664341C (en) 2018-11-06
BRPI0719539A2 (en) 2014-01-14
JP2010505879A (en) 2010-02-25
CN101534844A (en) 2009-09-16
AU2007303050A1 (en) 2008-04-10
AU2007303050B2 (en) 2013-11-07
US20080187604A1 (en) 2008-08-07
KR20090086210A (en) 2009-08-11
IL197945A (en) 2016-12-29
KR20150042291A (en) 2015-04-20
JP5303465B2 (en) 2013-10-02
KR101538727B1 (en) 2015-07-22
HK1132905A1 (en) 2010-03-12
CN101534844B (en) 2014-04-23
EP2068893A2 (en) 2009-06-17
WO2008043081A3 (en) 2008-05-29
CA2664341A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
MX2009003741A (en) Liquid chalcogenide compositions and methods of manufacturing and using the same.
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
MX2009000285A (en) Substituted piperidines that increase p53 activity and the uses thereof.
WO2006081252A3 (en) Use of 1-benzyl-1-hydr0xy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds as analgesics
WO2009077471A3 (en) Azolylmethyloxiranes, use thereof and agents containing the same
EG25261A (en) Liquid compositions for treating plant propagationmaterials.
UA105778C2 (en) Pyrazole-4-n-alcoxycarboxamides as microbiocides, a composition containing thereof, and a method for controlling infection of useful plants with phytopathogenic microorganisms or preventing thereto while using thereof
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
IL196543A (en) Pyridazinone derivatives and pharmaceutical compositions comprising them for use in the treatment of disorders
WO2008009379A3 (en) Active ingredient combinations having insecticide and acaricide properties
PL2162143T3 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
IL198626A0 (en) Core-1 positive microorganisms, compositions containing the same and methods of use thereof
WO2007124447A3 (en) Use of chalcogenides for treating shock and other adverse conditions
WO2009070740A3 (en) Novel compounds and compositions and methods of use
WO2004062613A3 (en) Hiv integrase inhibitors
TW200621268A (en) Antimicrobial copolymers and uses thereof
TW200740799A (en) Alpha2C adrenoreceptor agonists
WO2008049042A3 (en) Ophthalmic compositions containing diglycine
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
IL188861A0 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2009041014A1 (en) Sterilizing lubricant composition for conveyor, and use thereof
DE602004025808D1 (en) GABOXADOL FOR THE TREATMENT OF DEPRESSIONS AND OTHER AFFECTIVE DISORDERS
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
ZA200905126B (en) Use of compounds of formula (i) and/or (II) for the preservation of human or animal bodies, and compositions containing the same

Legal Events

Date Code Title Description
FG Grant or registration